Literature DB >> 17409601

Autoimmune pancreatitis with extreme elevation of DUPAN-2.

Shiho Mishima1, Yohei Mizuta, Takuji Yamao, Masaki Yamakawa, Yuko Akazawa, Ryosuke Mishima, Kazuo Ohba, Jun-ich Masuda, Ken Ohnita, Hajime Isomoto, Saburo Shikuwa, Katsuhisa Omagari, Shigeru Kohno.   

Abstract

An 80-year-old woman was admitted to our hospital with complaints of jaundice and liver dysfunction. She was found to have a high titer of serum IgG4, positive rheumatoid factor and marked elevation of DUPAN-2 (11,148 U/ml). Computed tomography showed swelling of the pancreas, and endoscopic retrograde cholangiopancreatography revealed diffuse irregular narrowing of the main pancreatic duct, which are typical findings of autoimmune pancreatitis. There was no evidence of malignancy. Administration of 30 mg/day of prednisolone was started. Computed tomography showed significant regression in the size of the pancreas, and the stenosis of the main pancreatic duct was improved on ERCP. The serum level of DUPAN-2 was also markedly decreased after the treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409601     DOI: 10.2169/internalmedicine.46.6184

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

Review 1.  Spontaneous regression of pancreatic cancer: real or a misdiagnosis?

Authors:  Marta Herreros-Villanueva; Elizabeth Hijona; Angel Cosme; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

2.  Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis.

Authors:  Raffaele Pezzilli; Silvia Vecchiarelli; Maria Cristina Di Marco; Carla Serra; Donatella Santini; Lucia Calculli; Dario Fabbri; Betzabè Rojas Mena; Andrea Imbrogno
Journal:  Case Rep Gastroenterol       Date:  2011-07-09

3.  Pembrolizumab-related pancreatitis with elevation of pancreatic tumour markers.

Authors:  Tamaki Kakuwa; Masao Hashimoto; Atsuko Izumi; Go Naka; Yuichiro Takeda; Haruhito Sugiyama
Journal:  Respirol Case Rep       Date:  2020-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.